Options: Hide MedDRA Preferred Terms , display all 22 labels
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abdominal pain | x | x | x | x | x | x | x | x | x | x | |||||||||||||
Combined hyperlipidaemia | x | x | x | x | x | x | |||||||||||||||||
Coronary heart disease | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||||||||
Diabetes mellitus | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||
Diabetic | x | x | x | x | x | x | x | ||||||||||||||||
Dyslipidaemia | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||
Fasting | x | ||||||||||||||||||||||
High density lipoprotein decreased | x | ||||||||||||||||||||||
Hypercholesterolaemia | x | x | x | x | x | x | x | x | x | x | |||||||||||||
Hyperlipidaemia | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||||||
Hyperlipoproteinemia | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||||||
Hypertriglyceridaemia | x | x | x | x | x | x | x | x | x | x | x | x | |||||||||||
Hypothyroidism | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||||||
Low density lipoprotein increased | x | ||||||||||||||||||||||
Myocardial infarction | x | ||||||||||||||||||||||
Pancreatitis | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||||||
Type IV hyperlipidaemia | x | x | x | x | x | x | x | x | x | x | x | x | |||||||||||
Type V hyperlipidaemia | x | x | x | x | x | x | x | x | x | x | |||||||||||||
Weight decreased | x | x | x | x | x | x | x | x | x | x | |||||||||||||
Xanthoma | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |